Cargando…

Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis

OBJECTIVE: The aim of this review was to collate all available evidence on the impact of point-of-care C reactive protein (CRP) testing on patient-relevant outcomes in children and adults in ambulatory care. DESIGN: This was a systematic review to identify controlled studies assessing the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbakel, Jan Y, Lee, Joseph J, Goyder, Clare, Tan, Pui San, Ananthakumar, Thanusha, Turner, Philip J, Hayward, Gail, Van den Bruel, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361331/
https://www.ncbi.nlm.nih.gov/pubmed/30782747
http://dx.doi.org/10.1136/bmjopen-2018-025036
_version_ 1783392671693275136
author Verbakel, Jan Y
Lee, Joseph J
Goyder, Clare
Tan, Pui San
Ananthakumar, Thanusha
Turner, Philip J
Hayward, Gail
Van den Bruel, Ann
author_facet Verbakel, Jan Y
Lee, Joseph J
Goyder, Clare
Tan, Pui San
Ananthakumar, Thanusha
Turner, Philip J
Hayward, Gail
Van den Bruel, Ann
author_sort Verbakel, Jan Y
collection PubMed
description OBJECTIVE: The aim of this review was to collate all available evidence on the impact of point-of-care C reactive protein (CRP) testing on patient-relevant outcomes in children and adults in ambulatory care. DESIGN: This was a systematic review to identify controlled studies assessing the impact of point-of-care CRP in patients presenting to ambulatory care services. Ovid Medline, Embase, Cochrane Database of Systematic Reviews, Cochrane CENTRAL, DARE, Science Citation Index were searched from inception to March 2017. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Controlled studies assessing the impact of point-of-care CRP in patients presenting to ambulatory care services, measuring a change in clinical care, including but not limited to antibiotic prescribing rate, reconsultation, clinical recovery, patient satisfaction, referral and additional tests. No language restrictions were applied. DATA EXTRACTION: Data were extracted on setting, date of study, a description of the intervention and control group, patient characteristics and results. Methodological quality of selected studies and assessment of potential bias was assessed independently by two authors using the Cochrane Risk of Bias tool. RESULTS: 11 randomised controlled trials and 8 non-randomised controlled studies met the inclusion criteria, reporting on 16 064 patients. All included studies had a high risk of performance and selection bias. Compared with usual care, point-of-care CRP reduces immediate antibiotic prescribing (pooled risk ratio 0.81; 95% CI 0.71 to 0.92), however, at considerable heterogeneity (I(2)=72%). This effect increased when guidance on antibiotic prescribing relative to the CRP level was provided (risk ratios of 0.68; 95% CI 0.63 to 0.74 in adults and 0.56; 95% CI 0.33 to 0.95 in children). We found no significant effect of point-of-care CRP testing on patient satisfaction, clinical recovery, reconsultation, further testing and hospital admission. CONCLUSIONS: Performing a point-of-care CRP test in ambulatory care accompanied by clinical guidance on interpretation reduces the immediate antibiotic prescribing in both adults and children. As yet, available evidence does not suggest an effect on other patient outcomes or healthcare processes. PROSPERO REGISTRATION NUMBER: CRD42016035426; Results.
format Online
Article
Text
id pubmed-6361331
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-63613312019-03-10 Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis Verbakel, Jan Y Lee, Joseph J Goyder, Clare Tan, Pui San Ananthakumar, Thanusha Turner, Philip J Hayward, Gail Van den Bruel, Ann BMJ Open General practice / Family practice OBJECTIVE: The aim of this review was to collate all available evidence on the impact of point-of-care C reactive protein (CRP) testing on patient-relevant outcomes in children and adults in ambulatory care. DESIGN: This was a systematic review to identify controlled studies assessing the impact of point-of-care CRP in patients presenting to ambulatory care services. Ovid Medline, Embase, Cochrane Database of Systematic Reviews, Cochrane CENTRAL, DARE, Science Citation Index were searched from inception to March 2017. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Controlled studies assessing the impact of point-of-care CRP in patients presenting to ambulatory care services, measuring a change in clinical care, including but not limited to antibiotic prescribing rate, reconsultation, clinical recovery, patient satisfaction, referral and additional tests. No language restrictions were applied. DATA EXTRACTION: Data were extracted on setting, date of study, a description of the intervention and control group, patient characteristics and results. Methodological quality of selected studies and assessment of potential bias was assessed independently by two authors using the Cochrane Risk of Bias tool. RESULTS: 11 randomised controlled trials and 8 non-randomised controlled studies met the inclusion criteria, reporting on 16 064 patients. All included studies had a high risk of performance and selection bias. Compared with usual care, point-of-care CRP reduces immediate antibiotic prescribing (pooled risk ratio 0.81; 95% CI 0.71 to 0.92), however, at considerable heterogeneity (I(2)=72%). This effect increased when guidance on antibiotic prescribing relative to the CRP level was provided (risk ratios of 0.68; 95% CI 0.63 to 0.74 in adults and 0.56; 95% CI 0.33 to 0.95 in children). We found no significant effect of point-of-care CRP testing on patient satisfaction, clinical recovery, reconsultation, further testing and hospital admission. CONCLUSIONS: Performing a point-of-care CRP test in ambulatory care accompanied by clinical guidance on interpretation reduces the immediate antibiotic prescribing in both adults and children. As yet, available evidence does not suggest an effect on other patient outcomes or healthcare processes. PROSPERO REGISTRATION NUMBER: CRD42016035426; Results. BMJ Publishing Group 2019-02-01 /pmc/articles/PMC6361331/ /pubmed/30782747 http://dx.doi.org/10.1136/bmjopen-2018-025036 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle General practice / Family practice
Verbakel, Jan Y
Lee, Joseph J
Goyder, Clare
Tan, Pui San
Ananthakumar, Thanusha
Turner, Philip J
Hayward, Gail
Van den Bruel, Ann
Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
title Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
title_full Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
title_fullStr Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
title_full_unstemmed Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
title_short Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
title_sort impact of point-of-care c reactive protein in ambulatory care: a systematic review and meta-analysis
topic General practice / Family practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361331/
https://www.ncbi.nlm.nih.gov/pubmed/30782747
http://dx.doi.org/10.1136/bmjopen-2018-025036
work_keys_str_mv AT verbakeljany impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT leejosephj impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT goyderclare impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT tanpuisan impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT ananthakumarthanusha impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT turnerphilipj impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT haywardgail impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis
AT vandenbruelann impactofpointofcarecreactiveproteininambulatorycareasystematicreviewandmetaanalysis